Balance Sheet Components (Tables)

6 Months Ended

Jun. 30, 2026

Balance Sheet Related Disclosures [Abstract]

Schedule of Prepaid Expenses and Other Current Assets

Prepaid expenses and other current assets as of June 30, 2026 and December 31, 2025 consist of the following (in thousands):


		June 30, 2026				December 31, 2025
Prepaid manufacturing and research expenses		$	3,214			$	1,908
Prepaid insurance			40				262
Prepaid professional fees			185				223
GST receivable			813				817
Other			391				422
Total prepaid expenses and other current assets		$	4,643			$	3,632

Schedule of Property and Equipment, Net

Property and equipment, net as of June 30, 2026 and December 31, 2025 consist of the following (in thousands):


		June 30, 2026				December 31, 2025
Equipment		$	223			$	223
Furniture and fixtures			18				18
Property and equipment, at cost			241				241
Less accumulated depreciation			(151	)			(112	)
Total property and equipment, net		$	90			$	129

Schedule of Other Assets

Other assets as of June 30, 2026 and December 31, 2025 consist of the following (in thousands):


		June 30, 2026				December 31, 2025
Clinical trial deposits		$	2,404			$	2,036
Other			146				25
Total other assets		$	2,550			$	2,061

Components of Accrued Liabilities

Accrued liabilities as of June 30, 2026 and December 31, 2025 consist of the following (in thousands):


		June 30, 2026				December 31, 2025
Accrued legal and professional fees		$	408			$	163
Accrued compensation			1,412				2,250
Accrued manufacturing and research expenses			2,999				7,374
Accrued issuance costs			40				40
Deferred R&D credit			1,337				927
Accrued other expenses			83				8
Total accrued liabilities		$	6,279			$	10,762